Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Viridian Therapeutics Inc (NASDAQ: VRDN) closed the day trading at $20.14 down -6.93% from the previous closing price of $21.64. In other words, the price has decreased by -$6.93 from its previous closing price. On the day, 1.83 million shares were traded. VRDN stock price reached its highest trading level at $21.72 during the session, while it also had its lowest trading level at $19.66.
Ratios:
For a better understanding of VRDN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.55 and its Current Ratio is at 18.55. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on September 11, 2024, Reiterated its Buy rating but revised its target price to $38 from $30 previously.
On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $29.
On June 06, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $23.Goldman initiated its Buy rating on June 06, 2024, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 27 ’24 when Beetham Thomas W. bought 5,000 shares for $23.41 per share. The transaction valued at 117,050 led to the insider holds 6,000 shares of the business.
Mahoney Stephen F. bought 21,400 shares of VRDN for $499,262 on Sep 27 ’24. The President and CEO now owns 21,400 shares after completing the transaction at $23.33 per share. On Sep 13 ’24, another insider, Fairmount Funds Management LLC, who serves as the Director of the company, bought 1,600,000 shares for $18.75 each. As a result, the insider paid 30,000,000 and bolstered with 3,445,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1595343872 and an Enterprise Value of 1054263744. For the stock, the TTM Price-to-Sale (P/S) ratio is 4949.19 while its Price-to-Book (P/B) ratio in mrq is 3.07. Its current Enterprise Value per Revenue stands at 3490.939 whereas that against EBITDA is -3.732.
Stock Price History:
Over the past 52 weeks, VRDN has reached a high of $27.20, while it has fallen to a 52-week low of $11.40. The 50-Day Moving Average of the stock is -11.03%, while the 200-Day Moving Average is calculated to be 17.35%.
Shares Statistics:
Over the past 3-months, VRDN traded about 1.46M shares per day on average, while over the past 10 days, VRDN traded about 1420480 shares per day. A total of 79.21M shares are outstanding, with a floating share count of 70.14M. Insiders hold about 11.45% of the company’s shares, while institutions hold 98.95% stake in the company. Shares short for VRDN as of 1730332800 were 10020094 with a Short Ratio of 6.85, compared to 1727654400 on 10151921. Therefore, it implies a Short% of Shares Outstanding of 10020094 and a Short% of Float of 14.979999999999999.
